» Articles » PMID: 30258876

Current Understanding and Dispute on the Function of the Wnt Signaling Pathway Effector TCF7L2 in Hepatic Gluconeogenesis

Overview
Journal Genes Dis
Date 2018 Sep 28
PMID 30258876
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Approximately 10 years ago, the Wnt signaling pathway effector TCF7L2 (=TCF-4) was recognized as a type 2 diabetes (T2D) risk gene through a genome wide association study (GWAS). As the correlation between polymorphisms and T2D susceptibility has been reproducibly observed by numerous follow-up investigations among different ethnic groups, great efforts have been made to explore the function of TCF7L2 in metabolic organs including the pancreas, liver and adipose tissues. Although these explorations have enriched our general knowledge on the Wnt signaling cascade in metabolic homeostasis, studies conducted to date have also generated controversial suggestions. Here I will provide a brief review on the Wnt signaling pathway as well as the milestone GWAS discovery and the follow-up studies. I will then discuss the two different opinions on the correlation between variants and T2D risk, a gain-of-function event versus a loss-of-function event. This will be followed by summarizing the relevant investigations on the metabolic function of hepatic TCF7L2 and presenting our view on the discrepancy and perspectives.

Citing Articles

Transcriptomic changes associated with PCK1 overexpression in hepatocellular carcinoma cells detected by RNA-seq.

Xiang J, Zhang Y, Tuo L, Liu R, Gou D, Liang L Genes Dis. 2020; 7(1):150-159.

PMID: 32181286 PMC: 7063442. DOI: 10.1016/j.gendis.2019.04.004.


Differentially Expressed mRNA Targets of Differentially Expressed miRNAs Predict Changes in the TP53 Axis and Carcinogenesis-Related Pathways in Human Keratinocytes Chronically Exposed to Arsenic.

Al-Eryani L, Waigel S, Tyagi A, Peremarti J, Jenkins S, Damodaran C Toxicol Sci. 2018; 162(2):645-654.

PMID: 29319823 PMC: 5889014. DOI: 10.1093/toxsci/kfx292.

References
1.
Oh K, Park J, Kim S, Oh H, Choi C, Koo S . TCF7L2 modulates glucose homeostasis by regulating CREB- and FoxO1-dependent transcriptional pathway in the liver. PLoS Genet. 2012; 8(9):e1002986. PMC: 3459990. DOI: 10.1371/journal.pgen.1002986. View

2.
Locke J, da Silva Xavier G, Rutter G, Harries L . An alternative polyadenylation signal in TCF7L2 generates isoforms that inhibit T cell factor/lymphoid-enhancer factor (TCF/LEF)-dependent target genes. Diabetologia. 2011; 54(12):3078-82. PMC: 3210366. DOI: 10.1007/s00125-011-2290-6. View

3.
Vacik T, Stubbs J, Lemke G . A novel mechanism for the transcriptional regulation of Wnt signaling in development. Genes Dev. 2011; 25(17):1783-95. PMC: 3175715. DOI: 10.1101/gad.17227011. View

4.
Columbus J, Chiang Y, Shao W, Zhang N, Wang D, Gaisano H . Insulin treatment and high-fat diet feeding reduces the expression of three Tcf genes in rodent pancreas. J Endocrinol. 2010; 207(1):77-86. DOI: 10.1677/JOE-10-0044. View

5.
Doble B, Woodgett J . GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci. 2003; 116(Pt 7):1175-86. PMC: 3006448. DOI: 10.1242/jcs.00384. View